Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2020-08-05 2020-08-04
Drug Identification Number 02230619 02230619
Brand name PEDIAPRED PEDIAPRED
Common or Proper name Pediapred Pediapred
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients PREDNISOLONE PREDNISOLONE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL
Packaging size 120ml 120ml
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-07-15 2020-07-15
Actual start date
Estimated end date 2020-08-14 2020-08-14
Actual end date 2020-08-04 2020-08-04
Shortage status Resolved Actual shortage
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments